Solution structure of two xenoantigens: αGal-LacNAc and αGal-Lewis X
Organ hyperacute rejection, a phenomenon occurring during discordant xenotransplantation, is due to the recognition of an oligosaccharide epitope by human xenoreactive natural antibodies. In addition to the αGal(1-3)βGal(1-4)GlcNAc trisaccharide, a fucosylated structure, αGal-Lewis X, has been shown...
Saved in:
Published in | Glycobiology (Oxford) Vol. 12; no. 4; pp. 241 - 250 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Oxford University Press
01.04.2002
Oxford University Press (OUP) |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Organ hyperacute rejection, a phenomenon occurring during discordant xenotransplantation, is due to the recognition of an oligosaccharide epitope by human xenoreactive natural antibodies. In addition to the αGal(1-3)βGal(1-4)GlcNAc trisaccharide, a fucosylated structure, αGal-Lewis X, has been shown to be recognized by the antibodies. Both the trisaccharide and the tetrasaccharide have been synthesized by chemical methods. A complete nuclear magnetic resonance characterization of the two compounds has been performed, including the measurements of two-dimensional nuclear Overhauser effect spectroscopy data. Molecular dynamics simulations were run for several ns in the presence of explicit water molecules. The combination of experimental and theoretical approaches revealed the effect of an additional fucose residue on the conformational behavior of the xenoantigen. This branched fucose strongly rigidifies the N-acetyllactosamine. The effect on the αGal(1-3)Gal fragment is less marked. In the presence of fucose, the terminal αGal residue can still adopt two different conformations, but the equilibrium populations are modified. |
---|---|
Bibliography: | Received on June 19, 2001; revised on August 31, 2001; accepted on August 31, 2001. ark:/67375/HXZ-S6PXV833-6 local:cwe123 istex:E5C1E8FC9F027F1FD19DB68536612A3288F15CF5 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0959-6658 1460-2423 |
DOI: | 10.1093/glycob/12.4.241 |